Compounds and methods for treament and diagnosis of Chlamydial infection

Details for Australian Patent Application No. 2004201702 (hide)

Owner Corixa Corporation

Inventors Fling, Steven P.; Bhatia, Ajay; Probst, Peter; Stromberg, Erica Jean; Jen, Shyian; Skeiky, Yasir A. W.

Agent Davies Collison Cave

Pub. Number AU-B-2004201702

Parent 769293

Filing date 22 April 2004

Wipo publication date 20 May 2004

Acceptance publication date 5 July 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/118 (2006.01) Medicinal preparations containing antigens or antibodies - Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 33/00 (2006.01) Antiparasitic agents

C07K 14/295 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/532 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Production of labelled immunochemicals

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C12R 1/01 (2006.01)

Event Publications

13 May 2004 Complete Application Filed

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2004201702

5 July 2007 Application Accepted

  Published as AU-B-2004201702

1 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201703-A wrapped food product

2004201701-Biazacyclic CRF antagonists